These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7033074)

  • 1. Treatment of early acute nonlymphatic leukemia with low dose cytosine arabinoside.
    Moloney WC; Rosenthal DS
    Haematol Blood Transfus; 1981; 26():59-62. PubMed ID: 7033074
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cytosine-arabinoside in the treatment of acute leukemias].
    Böhnel J; Gingold N; Hermansky F; Pawlowski M; Stacher A
    Wien Med Wochenschr; 1972 Apr; 122(15):203-7. PubMed ID: 4527321
    [No Abstract]   [Full Text] [Related]  

  • 3. Experience with the use of cytosine arabinoside in adult acute leukaemia.
    Brodie GN; Penny R
    Med J Aust; 1970 Mar; 1(13):635-7. PubMed ID: 5267173
    [No Abstract]   [Full Text] [Related]  

  • 4. Mitoxantrone and cytosine arabinoside (ARA-C) in adult acute leukemia: an interim report.
    Kansu E; Koc Y; Kars A; Alakavuklar M; Tekuzman G; Firat D
    J Chemother; 1989 Jul; 1(4 Suppl):1268-70. PubMed ID: 16312861
    [No Abstract]   [Full Text] [Related]  

  • 5. An attempt at synchronization of marrow cells in acute leukemia: relationship to therapeutic response.
    Kremer WB; Vogler WR; Chan YK
    Cancer; 1976 Jan; 37(1):390-403. PubMed ID: 1082365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary evaluation of cyclophosphamide (NSC-26271) and cytosine arabinoside (NSC-63878) in acute leukemia of children.
    Freedman MH; Finklestein JZ; Gilchrist GS; Hammond GD; Higgins GR; Hyman CB; Shore NA; Williams KO; Karon MR
    Cancer Chemother Rep; 1969 Oct; 53(5):299-303. PubMed ID: 5270583
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of acute myelocytic leukemia with low-dose cytosine arabinoside: results of a pilot study in four patients.
    Hagenbeek A; Sizoo W; Löwenberg B
    Leuk Res; 1983; 7(3):443-6. PubMed ID: 6350731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell kinetics in leukemia. Correlation with clinical features and response to chemotherapy.
    Vogler WR; Groth D; Garwood FA
    Arch Intern Med; 1975 Jul; 135(7):950-4. PubMed ID: 1080405
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination chemotherapy of adult acute nonlymphoblastic leukemia.
    Levi JA; Vincent PC; Gunz FW
    Ann Intern Med; 1972 Mar; 76(3):397-403. PubMed ID: 4502024
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute leukemia in adults: assessment of remission induction with combination chemotherapy by clinical and cell-culture criteria.
    Curtis JE; Cowan DH; Bergsagel DE; Hasselback R; McCulloch EA
    Can Med Assoc J; 1975 Aug; 113(4):289-94. PubMed ID: 1056807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of clinical studies with high-dose cytosine arabinoside at the M.D. Anderson Hospital.
    Keating MJ; Estey E; Plunkett W; Iacoboni S; Walters R; Kantarjian H; Andersson B; Beran M; McCredie KB; Freireich EJ
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):98-104. PubMed ID: 3859935
    [No Abstract]   [Full Text] [Related]  

  • 12. Modulation of cytosine arabinoside (ara-C) and high-dose ara-C in acute leukemia.
    Zittoun R; Marie JP; Zittoun J; Marquet J; Haanen C
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):139-43. PubMed ID: 3859928
    [No Abstract]   [Full Text] [Related]  

  • 13. [Combined treatment of myeloid leukemia with cytosine arabinoside and 6-mercaptopurine].
    Lawkowicz W; Polubiec A; Domańska B
    Pol Tyg Lek; 1973 Jun; 28(23):865-7. PubMed ID: 4515923
    [No Abstract]   [Full Text] [Related]  

  • 14. Accumulation of S-phase cells in the bone marrow of patients with acute leukemia by cytosine arabinoside.
    Büchner T; Barlogie B; Asseburg U; Hiddemann W; Kamanabroo D; Göhde W
    Blut; 1974 Apr; 28(4):299-300. PubMed ID: 4524531
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cytosine-arabinoside in the treatment of acute myeloblastic leukemias].
    Maroncelli P; Canova R; Casalino C; Fischioni P
    Minerva Med; 1971 Mar; 62(21):1110-9. PubMed ID: 5279670
    [No Abstract]   [Full Text] [Related]  

  • 16. High-dose cytosine arabinoside in the initial treatment of acute leukemia.
    Barnett MJ; Waxman JH; Richards MA; Ganesan TS; Bragman KS; Rohatiner AZ; Lister TA
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):133-8. PubMed ID: 3859927
    [No Abstract]   [Full Text] [Related]  

  • 17. Prediction of response of acute non-lymphocytic leukaemia to therapy with 'high dose' cytosine arabinoside.
    Peters WG; Willemze R; Colly LP; Colla L
    Br J Haematol; 1985 Apr; 59(4):733-4. PubMed ID: 3857074
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro and in vivo assessment of sensitivity to ara-C in myeloid leukemias.
    Raza A; Ucar K; Preisler HD; Mayers G
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):9-19. PubMed ID: 3892706
    [No Abstract]   [Full Text] [Related]  

  • 19. Low-dose cytosine arabinoside (Ara-C) therapy in the myelodysplastic syndromes and acute leukemia.
    Winter JN; Variakojis D; Gaynor ER; Larson RA; Miller KB
    Cancer; 1985 Aug; 56(3):443-9. PubMed ID: 3859362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low dose cytosine arabinoside in acute myeloid leukemia: remission is not due to differentiation induction.
    Pinkerton PH; London B; Cowan DH
    Am J Hematol; 1985 Aug; 19(4):415-7. PubMed ID: 3861090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.